Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study
2013 ◽
Vol 74
(3)
◽
pp. 526-531
◽
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 338.3-339
◽
2013 ◽
Vol 72
(Suppl 3)
◽
pp. A89.2-A89
◽
2019 ◽
Vol 28
(3)
◽
pp. 370-378
◽
2007 ◽
Vol 66
(8)
◽
pp. 1026-1032
◽